INR 6006.25
(0.05%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 139 Million INR | -6.71% |
2022 | 149 Million INR | -15.34% |
2021 | 176 Million INR | -1.68% |
2020 | 179 Million INR | 0.0% |
2019 | - INR | 0.0% |
2018 | - INR | 0.0% |
2017 | - INR | 0.0% |
2016 | - INR | 0.0% |
2015 | - INR | 0.0% |
2014 | - INR | 0.0% |
2013 | - INR | 0.0% |
2012 | - INR | 0.0% |
2011 | - INR | 0.0% |
2010 | - INR | 0.0% |
2009 | - INR | 0.0% |
2008 | - INR | 0.0% |
2007 | - INR | 0.0% |
2006 | - INR | 0.0% |
2005 | - INR | 0.0% |
2004 | - INR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | - INR | 0.0% |
2024 Q2 | 164 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q2 | 110 Million INR | 0.0% |
2023 FY | 139 Million INR | -6.71% |
2023 Q4 | 139 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 149 Million INR | 0.0% |
2022 FY | 149 Million INR | -15.34% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 149 Million INR | 0.0% |
2021 Q4 | 176 Million INR | 0.0% |
2021 Q2 | 198 Million INR | 0.0% |
2021 FY | 176 Million INR | -1.68% |
2021 Q1 | - INR | -100.0% |
2021 Q3 | - INR | -100.0% |
2020 Q4 | 179 Million INR | 0.0% |
2020 Q1 | - INR | 0.0% |
2020 Q2 | 201 Million INR | 0.0% |
2020 FY | 179 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2019 Q2 | - INR | 0.0% |
2019 FY | - INR | 0.0% |
2019 Q3 | - INR | 0.0% |
2019 Q4 | - INR | 0.0% |
2019 Q1 | - INR | 0.0% |
2018 FY | - INR | 0.0% |
2018 Q2 | - INR | 0.0% |
2018 Q1 | - INR | 0.0% |
2018 Q4 | - INR | 0.0% |
2018 Q3 | - INR | 0.0% |
2017 Q4 | - INR | 0.0% |
2017 FY | - INR | 0.0% |
2017 Q3 | - INR | 0.0% |
2017 Q2 | - INR | 0.0% |
2017 Q1 | - INR | 0.0% |
2016 Q4 | - INR | 0.0% |
2016 FY | - INR | 0.0% |
2016 Q1 | - INR | 0.0% |
2016 Q2 | - INR | 0.0% |
2016 Q3 | - INR | 0.0% |
2015 Q1 | - INR | 0.0% |
2015 Q4 | - INR | 0.0% |
2015 Q3 | - INR | 0.0% |
2015 Q2 | - INR | 0.0% |
2015 FY | - INR | 0.0% |
2014 Q3 | - INR | 0.0% |
2014 Q2 | - INR | 0.0% |
2014 Q1 | - INR | 0.0% |
2014 FY | - INR | 0.0% |
2014 Q4 | - INR | 0.0% |
2013 Q2 | - INR | 0.0% |
2013 Q3 | - INR | 0.0% |
2013 FY | - INR | 0.0% |
2013 Q1 | - INR | 0.0% |
2013 Q4 | - INR | 0.0% |
2012 Q3 | - INR | 0.0% |
2012 FY | - INR | 0.0% |
2012 Q4 | - INR | 0.0% |
2012 Q2 | - INR | 0.0% |
2011 FY | - INR | 0.0% |
2011 Q4 | - INR | 0.0% |
2010 FY | - INR | 0.0% |
2009 FY | - INR | 0.0% |
2008 FY | - INR | 0.0% |
2007 FY | - INR | 0.0% |
2006 FY | - INR | 0.0% |
2005 FY | - INR | 0.0% |
2004 FY | - INR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Abbott India Limited | 367.6 Million INR | 62.187% |
Cipla Limited | 2.25 Billion INR | 93.834% |
Gland Pharma Limited | 1.06 Billion INR | 86.953% |
GlaxoSmithKline Pharmaceuticals Limited | 64.69 Million INR | -114.868% |
Kopran Limited | 166.02 Million INR | 16.279% |
Marksans Pharma Limited | 1.9 Billion INR | 92.685% |
NGL Fine-Chem Limited | 7.44 Million INR | -1766.273% |
Pfizer Limited | 543.5 Million INR | 74.425% |
SMS Pharmaceuticals Limited | 1.22 Billion INR | 88.615% |
TTK Healthcare Limited | 7.98 Million INR | -1640.328% |